Blood vessels in the mammalian skeletal system control bone formation and support haematopoiesis by generating local niche environments. While a specialized capillary subtype, termed type H, has been recently shown to couple angiogenesis and osteogenesis in adolescent, adult and ageing mice, little is known about the formation of specific endothelial cell populations during early developmental endochondral bone formation. Here, we report that embryonic and early postnatal long bone contains a specialized endothelial cell subtype, termed type E, which strongly supports osteoblast lineage cells and later gives rise to other endothelial cell subpopulations. The differentiation and functional properties of bone endothelial cells require cell-matrix signalling interactions. Loss of endothelial integrin β1 leads to endothelial cell differentiation defects and impaired postnatal bone growth, which is, in part, phenocopied by endothelial cell-specific laminin α5 mutants. Our work outlines fundamental principles of vessel formation and endothelial cell differentiation in the developing skeletal system.
The skeletal system grows rapidly in embryonic and postnatal life, which requires tightly coordinated cell proliferation, differentiation and mineralization processes 1,2 together with a substantial expansion of the local vasculature. Chondrocytes and bone-forming osteoblasts release vascular endothelial growth factor (VEGF) and stimulate angiogenesis through the activation of VEGF receptors in endothelial cells (ECs) [3] [4] [5] [6] . Likewise, bone repair involves angiogenesis and osteoblast precursors enter fracture lesions along with invading blood vessels 7 . In addition to their essential transport function, vascular ECs release paracrine-acting signalling factors that control growth and regeneration in various organs [8] [9] [10] [11] [12] . In the skeletal system, osteogenesis has been associated with a specific capillary EC subtype, termed type H, which shows high expression of the markers CD31/PECAM1 and endomucin (CD31 hi Emcn hi ) and is found in the metaphysis and endosteum of postnatal long bone 11, 13 . In addition to mediating angiogenic growth, type H ECs provide molecular signals acting on osteoprogenitor cells and thereby couple angiogenesis and osteogenesis. By contrast, type L (CD31 lo Emcn lo ) ECs, characterized by relatively low CD31 and Emcn expression, form the bone marrow sinusoidal vessel network and are not associated with osteoprogenitors expressing the transcription factor osterix (Osx) 11, 13 . Interestingly, impairment of the function of bone-degrading osteoclasts by cathepsin K (CTSK) inhibitors, a treatment that might help to prevent bone loss in osteoporosis and other disease conditions, led to an increase of CD31 hi Emcn hi capillaries in mice, arguing that type H vessels might have therapeutic relevance 14 .
Extracellular matrix (ECM) molecules promote mineralization and regulate the behaviour of osteoblasts and of bone-degrading osteoclasts [15] [16] [17] . Cell-matrix interactions are frequently mediated by integrin receptors, composed of α and β subunits, which can bind a wide range of ECM proteins but also soluble factors and cell surface proteins 18, 19 . Integrin β1, a subunit that can partner with 12 different α chains, is an important regulator of EC function. EC-specific inactivation of Itgb1, the gene encoding β1 integrin, is incompatible with embryonic angiogenesis and survival beyond midgestation [20] [21] [22] . Inducible genetic strategies have shown that integrin β1 controls arteriolar lumen formation 23 as well as postnatal vessel growth and endothelial barrier function 24 .
While these previous studies have focused on well-established models of embryonic and postnatal angiogenesis, insight into endothelial cell-matrix interactions in the developing skeletal system is lacking. In addition, it is not known how different EC subtypes are 100 µm 100 µm 100 µm mp dp dp 100 µm Supplementary Table 6 .
specified during bone morphogenesis. By combining high-resolution confocal imaging, RNA sequencing and mouse genetics, we provide insight into these important questions and outline fundamental principles of vessel growth and EC specialization.
RESULTS

Developmental vascularization of long bone
As reported previously 3, 5, 7, 25 , vascularization of murine femur is initiated at embryonic day (E) 14.5. In a process resembling sprouting angiogenesis ( Fig. 1a and Supplementary Fig. 1a ), blood vessels entered the initially avascular cartilage containing hypertrophic chondrocytes and by E15.5 the primary ossification centre contained a highly branched vessel plexus ( Fig. 1a and Supplementary Fig. 1a ). Later, long bones expanded both longitudinally and radially, which was accompanied by expansion of the local vasculature ( Fig. 1b ). From postnatal day (P) 6 onwards, morphologically distinct capillary populations became visible in the metaphysis and diaphysis ( Fig. 1b and Supplementary Fig. 1b ). Metaphyseal capillaries displayed a column-like structure 13 , while the diaphysis contained a dense sinusoidal network surrounded by haematopoietic cells (Fig. 1c and Supplementary Fig. 1b ). Metaphyseal and diaphyseal capillary beds were interconnected by a transition zone, which contained sprouts and thin endothelial connections indicative of vascular remodelling ( Supplementary Fig. 1b ). As previously shown for 4-week-old long bone 13 , metaphyseal but not diaphyseal capillary ECs showed high expression of CD31 and Emcn at P0, P6 and P14 (Fig. 1c ).
Previous work has indicated that type H EC abundance declines during adult life 13 . Flow cytometry analysis of long bone showed that the Emcn hi CD31 hi EC fraction was highest around birth and gradually decreased during the first 4 weeks postnatally ( Fig. 1d ). During the same period, Osx + cells expanded rapidly indicating bone growth ( Fig. 1e and Supplementary Fig. 1c ).
Characterization of a third bone EC subpopulation
Flow cytometry analyses using the same settings as established for P21 ( Fig. 1d ) revealed the existence of a third, previously not described subpopulation of bone ECs (Fig. 2a ). Emcn hi CD31 hi clusters from E16.5, P6 and P14 femur were found in two distinct locations in twodimensional plots and argued for a separate EC subset in addition to type H endothelium ( Fig. 2a ). We termed this population type E because of its high abundance in embryonic long bone at E16.5, while type H cells were comparably rare at this stage ( Fig. 2b) . Type E EC abundance decreased postnatally to 3.8% at P14 and 2.2% at P28, respectively. The fraction of type H ECs initially increased during early postnatal life, peaked at P6 and was already in decline at P14. In accordance with the high abundance of sinusoidal (type L) endothelium in adult bone 13 , Emcn lo CD31 lo ECs increased continuously throughout all postnatal stages analysed and represented the major population after P6 ( Fig. 2b) .
To gain insight into their molecular properties, type H, E and L ECs were sorted by flow cytometry from P6 bones in triplicate. Principal component analysis of RNA-sequencing samples showed low variation within each sample group, while sample clustering indicated distinct profiles of individual EC populations ( Fig. 2c ). Expression profiles of type E and H ECs were more similar to each other than to type L. Differential gene expression analysis for every possible pairwise combination of samples, with a false discovery rate (FDR)-adjusted P value <0.01 and an absolute log 2 fold change >1 identified 3,324 differentially expressed genes for type H versus L, 4,602 for type E versus L, and 1,619 for type E versus H ( Fig. 2d and Supplementary  Fig. 2a ). A high proportion of genes (1, 645) was upregulated in both E and H subtypes relative to type L cells, while 828 and 350 genes were specifically higher in type E and H, respectively ( Fig. 2e ). RNAsequencing results were confirmed by quantitative PCR with reverse transcription (RT-qPCR) for a panel of 14 genes. R 2 values of 0.98 for type H versus L, 0.93 for type E versus L, and 0.90 for type E versus H indicate high correlation of results ( Supplementary Fig. 2b ). RNA-seq results for Emcn and Pecam1 confirmed enrichment of these markers in type H and E ECs relative to type L ( Fig. 2f ). Consistent with the flow cytometry data, type E cells showed higher Pecam1 and lower Emcn transcription than type H ECs ( Fig. 2a ,f).
Analysis of selected markers showed high expression of Vegfr2/Kdr and Vegfr3/Flt4 in type H and E ECs relative to type L endothelium ( Fig. 2g ). Both genes encode VEGF receptors and regulate angiogenesis in numerous settings [26] [27] [28] [29] [30] . Surprisingly, anti-VEGFR2 immunostaining labelled column-shaped type H vessels less than the adjacent type L network ( Supplementary Fig. 2c ). VEGFR3 protein was also low on type H columns, whereas the most distal type H vessels next to the growth plate and the sinusoidal network were strongly stained ( Supplementary Fig. 2d ). As VEGF receptors undergo rapid turnover in the growing retinal vasculature 31 , mice were injected with the proteasome inhibitor MG132, which limits the availability of ubiquitin and interferes with protein degradation 32 . MG132 led to elevated VEGFR2 and VEGFR3 staining of type H vessel columns, whereas changes in diaphyseal vessels were comparably modest ( Fig. 2h ,i and Supplementary Fig. 2e ,f). This validated the corresponding RNA-seq and RT-qPCR results and indicated high turnover and low steadystate levels of VEGF receptors in type H vessels.
Functional properties of type E ECs
Further analysis and validation of RNA-seq results enabled the identification of markers that were expressed at high levels in type E endothelium relative to other EC subtypes, including Esm1, Kitl, Unc5b, Bcam, Cav1 and Apln ( Supplementary Fig. 3a ). In P6 femur, the type E-enriched markers caveolin 1 and BCAM/CD239/Lutheran blood group glycoprotein, a specific receptor for laminin 511 in blood cells 33 , showed expression in Emcn-negative arterioles, which therefore did not correspond to type E ECs, as well as in Emcn + capillaries in compact bone and endosteum ( Fig. 3a-c ). In E16.5 femur, most capillaries were CD31 + (Fig. 1c ) and a fraction also showed expression of caveolin 1 ( Supplementary Fig. 3b ). Cross-sections through P6 femur showed caveolin 1 + or BCAM + vessels in the endosteum and the adjacent compact bone (Fig. 3b ,c and Supplementary Fig. 3c ). Interestingly, type E vessels were even more strongly associated with Osx + osteoprogenitors than type H capillaries ( Fig. 3c,d ), which we attribute to high expression of bone morphogenetic proteins (BMPs) and of other factors controlling angiogenesis and osteogenesis ( Fig. 3e ). When cocultured with murine mesenchymal C3H10T1/2 cells 34 , freshly isolated type H or type E ECs induced remodelling of cell spheroids and expression of osteoblast lineage markers ( Fig. 3f ,g and Supplementary  Fig. 3d,e ). In contrast, spheroids consisting of C3H10T1/2 cells and type L ECs lacked osteoblast lineage differentiation ( Fig. 3f,g and Supplementary Fig. 3d ,e).
As apelin (encoded by the Apln gene) was one of the markers enriched in type E ECs, we performed in vivo fate mapping with Apln-CreER knock-in mice 35 . Following a single administration of 4-hydroxy tamoxifen (4-OHT) at E15.5, Apln-CreER-induced expression of green fluorescent protein (GFP) under control of the R26-mT/mG Cre reporter 36 labelled ECs throughout the E16.5 and E18.5 femur, which predominantly represented type E endothelium ( Fig. 4a,b and Supplementary Fig. 4a ). At P6, GFP + ECs were highly abundant and had contributed to metaphyseal type H capillaries, type L sinusoids in the diaphysis and arteries ( Fig. 4b and Supplementary  Fig. 4a ). Following 4-OHT administration to Apln-CreER R26-mT/mG newborn animals (P0), GFP + ECs were observed at P1 in type H capillaries near the growth plate and in endosteum and compact bone, that is, in sites enriched in type E endothelium ( Fig. 4c and Supplementary Fig. 4b ). At P6, GFP + ECs were highly abundant in arteries and all capillary subtypes ( Fig. 4c and Supplementary Fig. 4b ).
Induction of Apln-CreER R26-mT/mG animals with 4-OHT at P6 showed that labelled ECs were initially concentrated in the distal metaphysis, endosteum and compact bone at P7, whereas a substantial expansion of the GFP + endothelium into all capillary subtypes and arteries was seen at P11, P15 and P21 ( Fig. 4d and Supplementary  Fig. 4c ). Flow cytometry of P6-injected Apln-CreER R26-mT/mG bone ECs at P7 showed enrichment of type E ECs in the GFP + population, but in contrast to E16.5, the fraction of type H ECs was substantially increased (Fig. 4a,e ). Analysis of P6-injected Apln-CreER R26-mT/mG mice at P7 and P21 indicated a significant increase in GFP + type L ECs (Fig. 4f ). Together, these data show that type E vessels represent a spatially and temporally confined subpopulation of capillaries in developing bone. Characteristic features of type E ECs are their strong association with Osx + cells and capacity to promote osteogenesis. Moreover, type E ECs can give rise to type H endothelium and both subtypes can differentiate into type L and arterial ECs during postnatal development. Nuclei, Hoechst (blue). GFP signal marks type E (red arrowheads) and a subset of type H ECs (arrows) one day after CreERT2 activation, whereas GFP + ECs were seen in all capillary subpopulations (including type L, white arrowheads) and arteries (yellow arrowheads) at the respective later stages. (e) Flow cytometric analysis of GFP + cells in P7 Apln-CreER R26-mT/mG long bone at 24 h after 4-OHT administration (n = 7 mice). (f) Flow cytometry analysis of GFP + type L ECs in Apln-CreER R26-mT/mG mice at P7 and P21 after 4-OHT induction at P6. Note the significant increase of labelled type L ECs. Data represent mean ± s.e.m. (n = 7 mice for P7 and n = 8 mice for P21), (P = 0.008, two-tailed unpaired t-test). (g) Gene-set enrichment analysis for significantly differentially regulated genes in type E or type H ECs relative to type L ECs. Cell-matrix adhesion-related gene sets are highlighted in yellow.
Enrichment of cell-matrix adhesion molecules in type H and E ECs
To unravel the biological relevance of the RNA-seq data set, we performed Generally Applicable Gene-set Enrichment for Pathway Analysis (GAGE) 37 . Altogether 78 gene sets displayed significant levels of upregulation in type E versus L, while 76 gene sets were upregulated in type H versus L ECs (q value <0.0001 and Supplementary Tables 1,2). Representation of the top 15 upregulated gene sets in type E versus L and type H versus L ECs showed a striking enrichment of ECM, basement membrane and cell adhesion components ( Fig. 4g ).
In particular, RNA-seq and RT-qPCR data indicated high expression of Lama4 and, to a lower extent, Lama5 in type E and H ECs ( Supplementary Fig. 4d ). Both encode alpha subunits of heterotrimeric laminins that are central constituents of the endothelial basement membrane and control cell behaviour 38 . By contrast, Fn1 transcripts (encoding fibronectin) were comparable in all three EC subtypes ( Supplementary Fig. 4d ). Transcripts for integrins were also enriched in type E and H ECs relative to type L ( Supplementary Fig. 4e-g) . Accordingly, strong vascular staining was seen for laminin α4, laminin α5, fibronectin, and the integrin β1 subunit in P6 or P21 femoral metaphysis ( Supplementary Fig. 4h -j). Anti-integrin β1 staining also decorated the type L endothelium of the diaphysis, whereas the interstitial matrix proteins collagen type I and osteopontin labelled trabecular bone in the metaphysis ( Supplementary Fig. 4i ,j).
The phenotype of bone ECs is controlled by endothelial integrin β1
To analyse integrin function in the endothelium of developing bone, Cdh5(PAC)-CreERT2 transgenic animals 39 were interbred with mice carrying loxP-flanked alleles of Itgb1 40 . Cdh5(PAC)-CreERT2 activity is strictly EC-specific at P21 ( Supplementary Fig. 5a ,b) and all other stages investigated previously 13 . As tamoxifen administration during embryonic development led to rapid lethality of the resulting Itgb1 i EC mutants 24 , only postnatal mutants generated by tamoxifen injection from P10-P12 were analysed. Efficient Itgb1 inactivation was confirmed by RT-qPCR of freshly isolated bone ECs at P21 ( Supplementary Fig. 5c ). Three-week-old Itgb1 i EC mutants were smaller and had significantly lower body weight than control littermates ( Supplementary Fig. 5d ). Freshly isolated mutant femurs were 9% shorter than controls, displayed a dark red colour and contained a disorganized vasculature ( Fig. 5a and Supplementary  Fig. 5e ,f). Type H vessel columns were much shorter, whereas the rest of the metaphyseal capillaries were highly branched and lacked a straight columnar organization (Fig. 5b,c ). VEGFR3 immunostaining, with the distinct low steady-state levels of the protein in type H EC columns ( Supplementary Fig. 2d ), highlighted the loss of Itgb1 i EC columnar vessels ( Fig. 5d,e ). Reflecting the reduced expansion of Itgb1 i EC long bone, the number of ECs was slightly but significantly increased despite reduced EC proliferation ( Fig. 5f,g) . Arteries, which connect to type H capillaries in metaphysis and endosteum 13 , were present both in Itgb1 i EC and control femurs ( Supplementary Fig. 5g ). Flow cytometry analysis of Itgb1 i EC femoral ECs showed an unexpected increase in CD31 hi Emcn hi cells ( Fig. 5h ) and immunohistochemistry showed strong CD31 signal in diaphyseal sinusoidal vessels ( Fig. 5i ). Moreover, proliferation of mutant CD31 hi Emcn hi ECs was strongly reduced, whereas no significant change was seen in the type L subset ( Fig. 5j and Supplementary Fig. 5h ,i). Flow cytometry analysis of Itgb1 i EC bone ECs indicated that the increase in CD31 hi Emcn hi cells was also in part attributable to expansion of the type E subset (Fig. 5k ). Together, this indicated that the loss of endothelial integrin β1 leads to substantial phenotypic changes in bone ECs. Significantly more ECs showed elevated expression of the markers CD31 and Emcn but lacked the normal morphological and functional properties of type E or H endothelium. These changes were accompanied by alterations in regional metabolic properties. The non-hypoxic zone in the distal metaphysis 13 was shortened, whereas phosphorylated mitogenactivated protein kinase (phospho-Erk1/2), a marker of high metabolic activity, was decreased ( Supplementary Fig. 5j ,k).
Regulation of osteogenesis by endothelial integrin β1
Bone angiogenesis and CD31 hi Emcn hi ECs are tightly coupled to osteogenesis 7, 13 . Micro-computed tomography (µCT) analysis of the P21 Itgb1 i EC tibial metaphysis uncovered profound structural defects in bone formation (Fig. 6a ). Mutants displayed significantly reduced bone volume, trabeculae number and trabecular thickness, whereas trabecular separation was increased. Connectivity density of trabecular bone was slightly but not significantly decreased ( Fig. 6a) . Accordingly, the abundance of Osx + cells was strongly reduced in EC-specific Itgb1 mutants (Fig. 6b,c) . Osteocalcin, a marker for mature osteocytes, was also profoundly decreased in Itgb1 i EC mice (Fig. 6d ). Analysis of collagen type I and osteopontin, which are potential binding partners of integrin β1, revealed reduction of those proteins. Mutants displayed lower staining intensities than control samples and the length of trabecular segments was reduced, which was confirmed by visualization of matrix-rich structures by secondharmonic generation imaging using multi-photon microscopy ( Fig. 6e and Supplementary Fig. 6a -c). Furthermore, immunostaining for the proteoglycan NG2/Cspg4 and the transcription factor Runx2, markers for primitive mesenchymal cells and preosteoblasts, respectively, was enhanced in Itgb1 i EC femurs relative to littermate controls, suggesting defective maturation of osteoblast progenitors ( Fig. 6f,g) . Thus, postnatal loss of endothelial integrin β1 leads to profound bone formation defects, which are presumably caused by loss of the proosteogenic properties of CD31 hi Emcn hi ECs and reduced expression of potential paracrine regulators 11, 13 such as Pdgfb, Tgfb3 and Dll4 (Fig. 6h ). Arguing that bone defects are not caused by increased osteoclast activity, calcitonin receptor and TRAP (tartrate-resistant acid phosphatase) staining was reduced in Itgb1 i EC bone sections ( Supplementary Fig. 6d,e ). Serum levels of parathyroid hormone and calcitonin, hormones controlling bone remodelling, were not significantly changed ( Supplementary Fig. 6f ).
To address whether preferential gene inactivation in Emcn hi CD31 hi ECs would reproduce defects seen in pan-endothelial mutants, Apln-CreER and Itgb1 conditional mice were interbred. Administration of tamoxifen from P10-P12 predominantly led to GFP expression in metaphyseal and endosteal type H ECs in Apln-CreER R26-mT/mG animals at P13, whereas no GFP signals were seen in the absence of tamoxifen ( Supplementary Fig. 7a -c). As shown above, the initially labelled EC population expanded substantially and, by P21, GFP + cells were seen in arteries, veins and throughout the different bone capillary networks ( Supplementary  Fig. 7d ). Apln-CreER-controlled Itgb1 i Apln mutants generated with the same scheme of tamoxifen administration showed disorganization of the metaphyseal vasculature, disruption of type H capillary columns and the appearance of ectopic interconnections, shortening of the vessel region with low VEGFR3 immunostaining, and increases in total and CD31 hi Emcn hi ECs with only minor changes in the type L subpopulation ( Fig. 7a-d ). In addition to these vascular alterations, Itgb1 i Apln mutants also phenocopied the reduction in Osx + cells and osteopontin deposition, the increase in Runx2 preosteoblasts, and the reductions in body weight, femur length, mineralized bone and TRAP staining seen in pan-endothelial Itgb1 i EC animals (Fig. 7e-g and Supplementary Fig. 7e-i) . GFP + cells, generated by the activation of the R26-mT/mG reporter in the Itgb1 i Apln background, were confined to the metaphysis and showed defective expansion into the diaphysis (Fig. 7h) population was significantly reduced in Itgb1 i Apln mutants (Fig. 7i ) arguing that integrin β1 is required for the expansion of CD31 hi Emcn hi ECs and their conversion into type L ECs.
Role of matrix molecules in the specification of bone ECs
Given the numerous important roles of matrix proteins in bone formation [15] [16] [17] , we wanted to identify ECM components interacting with endothelial integrin β1. Global deletion of Lama4 did not result in any overt phenotype in P21 femur. Vascular organization was normal, the length of metaphyseal columnar vessels and Osx immunostaining were comparable to controls, and total and CD31 hi Emcn hi bone ECs were not altered (Fig. 8a,b and Supplementary Fig. 8a-c) .
Osteopontin-deficient (Spp1 KO ) mice had weak defects resembling certain aspects of the Itgb1 i EC phenotype. Metaphyseal vessel columns were shortened and branching between columns was increased, and Osx + cells and the VEGFR3-low area within the metaphyseal vessel columns were slightly reduced ( Fig. 8c,d ; Supplementary Fig. 8d ). However, the total number of ECs was not significantly changed and the CD31 hi Emcn hi subpopulation was decreased in Spp1 KO long bone (Fig. 8e ).
As global Lama5 knockout mice are embryonic lethal 41 , bone from constitutive EC-specific Lama5 mutants 42 (Lama5 EC ) was analysed, which showed defects resembling major aspects of Itgb1 i EC mutants even though the overall phenotype was comparably milder. Vessel columns near the Lama5 EC growth plate were shortened, branching within the metaphyseal vasculature was increased, and the VEGFR3low vessel area, Osx + cells and femur length were reduced (Fig. 8f-h and Supplementary Fig. 8e-h) . Mineralized bone, however, was not reduced significantly ( Supplementary Fig. 8i,j) . While the total number of Lama5 EC bone ECs was not substantially altered, the Emcn hi CD31 hi fraction was significantly increased (Fig. 8i ). The analysis of selected transcripts in freshly isolated ECs by RT-qPCR indicated strongly reduced expression of Lama5 and Itgb1 in the Lama5 EC bone endothelium (Fig. 8j ). Expression of Lama4 and Fgf1 was increased, while levels of Bmp2 and Dll4 were slightly but significantly decreased.
These results indicate that disrupted cell-matrix interactions contribute, at least in part, to the defects in Itgb1 mutant bone. While it is likely that several ECM molecules are relevant in this context, our data argue for roles of osteopontin and the laminin α5 subunitcontaining laminin 511 or 521 isoforms, which are produced by ECs 43 and deposited in the subendothelial basement membrane.
DISCUSSION
ECs are highly heterogeneous in terms of gene expression, morphology and functional specialization 44, 45 . While differences between arterial and venous or lymphatic and blood vessel ECs are widely recognized, much less is known about the existence and specification of distinct capillary subsets. In kidney, glomerular capillaries are part of the renal ultrafiltration system, whereas peritubular capillaries surrounding nephron tubules participate in ion and mineral reabsorption 46, 47 . In adult brain, neurogenesis occurs in the adult subventricular zone and the hippocampal subgranule zone, which contain neural stem cells and vessels that are morphologically and functionally distinct from other brain capillaries 48, 49 . Specific properties of distinct capillary subtypes are perhaps best documented for the skeletal system. Type H capillary ECs support osteogenesis, whereas type L ECs form the sinusoidal vessel network of the bone marrow cavity 13 . However, the molecular signatures of the different capillary EC subtypes and the processes controlling their specification have remained unknown. Our current study not only provides unbiased insight into the molecular properties of bone ECs but also establishes the existence of a third capillary EC subpopulation, termed type E, with high capacity to support perivascular Osx + osteoprogenitors in embryonic and early postnatal bone. While type E cells predominate in early long bone, genetic lineage tracing supports the existence of type E-to-H and type H-to-L conversion processes, which accompany the rapid developmental expansion of bone and bone marrow. On the basis of the sum of the findings presented here, we propose a developmental and functional hierarchy of bone ECs where type E cells occur upstream of type H and type L endothelium. Similar principles are likely to apply to other organ systems where, however, the identity, localization and functional roles of specific capillary EC subsets remain to be uncovered.
ECM molecules and cell-matrix receptors were particularly enriched in the type E and type H gene expression profiles. Integrin family cell-matrix receptors are well known for their important roles in a wide range of cell differentiation processes 50, 51 . Our data establish that the β1 subunit is essential for the normal specification and function of bone EC subpopulations. In addition to matrix, integrins can bind and signal in response to growth factors and other secreted molecules [52] [53] [54] [55] . However, Itgb1 i EC defects were partially phenocopied in Lama5 EC and, to a lesser extent, in Spp1 global knockout mice, which argues for a role of cell-matrix signalling in bone EC specification. A caveat of the genetic approaches in our study is that they affect ECs throughout the body and might therefore potentially influence processes in the skeletal system indirectly. Nevertheless, the data presented here argue that integrin β1 and laminin α5 are required in bone ECs in a cell-autonomous and direct fashion. Thus, our findings raise the possibility that changes in the matrix environment of bone, which are the result of congenital defects and other pathological conditions in human patients [56] [57] [58] , might potentially lead to diseasepromoting alterations in the vasculature. Our identification and characterization of distinct, functionally specialized capillary EC subsets might facilitate the characterization of disease-associated changes in the future.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. DOI: 10.1038/ncb3476 METHODS Mouse models. C57BL/6J mice were used for the analysis of wild-type bones. For embryonic stages, females were checked for the presence of a vaginal plug in the morning.
Lineage tracing experiments were performed by mating Apln-CreER mice 59 and R26-mG/mT reporter animals 36 . Cre activity and GFP expression were induced by intraperitoneal injection of 4-hydroxy tamoxifen (4-OHT) (H7904, Sigma). Induction was performed at E15.5 (750 µg 4-OHT per female), P0 (15 µg 4-OHT per pup) and P6 (25 µg 4-OHT per pup). For postnatal analysis after embryonic induction, cesarean sections were performed at E19.5 and pups were raised by foster mothers. As the Apln-CreER knock-in allele disrupts the function of the X-linked
Apln gene 59 , only females were analysed. For inducible and EC-specific genetic experiments, Cdh5(PAC)-CreERT2 transgenics 39 were interbred with mice carrying loxP-flanked Itgb1 (Itgb1 lox/lox ) alleles 40 . Cre activity and gene inactivation were induced by intraperitoneal injection of 200 µg tamoxifen (T5648, Sigma) from postnatal day 10 to 12. At the age of 3 weeks, femurs and tibiae were collected from Itgb1 lox/lox Cdh5(PAC)-CreERT2 T/+ mice and Cre-negative Itgb1 lox/lox littermate controls.
The specificity of Cdh5(PAC)-CreERT2 transgenic animals for ECs in long bone was determined by crossing Cdh5(PAC)-CreERT2 mice with R26-mT/mG 36 reporter mice. Cre activation was induced from P10 to P12 and mice were analysed at P21. Furthermore, the Apln-CreER was introduced into the R26-mT/mG reporter background for tracking of Apln + ECs with the same induction and analysis scheme.
For gene inactivation in Apln + ECs, Apln-CreER was bred into the Itgb1 lox/lox background. Gene inactivation was induced by tamoxifen administration from P10 to P12 (200 µg per pup per day). Long bones were collected at the age of 3 weeks from Itgb1 lox/lox Apln-CreER T/+ (Itgb1 i Apln ) mice and Cre-negative Itgb1 lox/lox littermate controls. Furthermore, Itgb1 i Apln mice were interbred with R26-mT/mG reporters. The resulting Itgb1 lox/lox R26-mT/mG lox/+ Apln-CreER T/+ and Itgb1 +/+ R26-mT/mG lox/+ Apln-CreER T/+ mice were analysed at 3 weeks of age after tamoxifen administration from P10 to P12.
The role of endothelial Lama5 was investigated by crossing mice carrying loxPflanked Lama5 alleles 42 with Tek-Cre transgenics 60 . In addition, global Lama4 −/− 61 and Spp1 −/− knockout mice 62 were used. Genotypes of mice were determined by PCR.
All animal experiments were performed in compliance with the relevant laws and institutional guidelines, were approved by local animal ethics committees and were conducted at the University of Münster and the MPI for Molecular Biomedicine with permissions granted by the Landesamt für Natur, Umwelt und Verbraucherschutz (LANUV) of North Rhine-Westphalia. Animals were combined in groups for experiments irrespective of their sex. Apln-CreER knock-in males were excluded from analysis because these mice lack expression of the X-linked Apln gene. The investigators were not blinded to allocation during experiments and outcome assessment. Experiments were not randomized and no statistical method was used to predetermine sample size, which was, instead, chosen according to previous experiments.
Proteasome inhibition, EdU labelling and hypoxia analysis.
Three-week-old wild-type mice were injected intraperitoneally with 50 µg g −1 MG132 (Millipore, no. 474790) in dimethylsulfoxide (DMSO; Sigma, D8418) or with DMSO alone as a vehicle control. Three hours after injection, femurs were dissected and processed for immunostaining as described above.
Proliferating cells in vivo were labelled by intraperitoneal injection of 500 µg of EdU (Invitrogen) 2 h before the analysis. Detection of proliferating cells in fixed bone sections and in flow cytometry analysis was achieved with staining according to the manufacturer's instructions (Invitrogen).
Hypoxic cells were detected with the hypoxia probe pimonidazole (Pimo, Hypoxyprobe Inc.) according to the manufacturer's instructions. Mice were intraperitoneally injected with 60 mg kg −1 Pimo 2 h before analysis.
Bone immunohistochemistry. Murine femurs and tibiae were dissected, cleaned from adjacent muscles, immediately transferred into cold 2% paraformaldehyde solution and fixed overnight at 4 • C under rotation. Next, bones were transferred into 0.5 M EDTA solution and kept overnight at 4 • C under rotation for decalcification. On the following day, EDTA was exchanged for 20% sucrose and 1% polyvinylpyrrolidone (PVP) solution. After 24 h at 4 • C under rotation, bones were embedded and frozen in 8% gelatin (porcine) with 15% sucrose and 1.5% PVP. Finally, samples were cut into 100 µm sections using low-profile blades on a Leica CM3050 cryostat.
For immunofluorescence staining, sections were air-dried at room temperature, rehydrated in PBS and permeabilized with 0.3% Triton X-100 for 15 min at room temperature. After washing with PBS, blocking solution (5% donkey serum +0.1% Triton X-100) was applied for 20 min at room temperature. Following another PBS wash, sections were treated with primary antibodies overnight at 4 • C. The next day, sections were washed four times with PBS and incubated with secondary antibodies for 1.5 h at room temperature. After five wash steps with PBS, sections were mounted using FluoroMount-G (Southern Biotech). Finally, coverslips were sealed with nail polish.
The following primary antibodies were used: rat anti-endomucin (sc-65495, Santa Cruz, diluted 1:100), goat anti-CD31 conjugated to Alexa Fluor (AF) 488 (FAB3628G, R&D Systems, 1:50), rabbit anti-osterix (c-22536-R, Santa Cruz, 1:500), goat anti-VEGFR2 (AF644, R&D Systems, 1:50), goat anti-VEGFR3 (AF743, R&D Systems, 1:50), rabbit anti-caveolin 1 (no. 3238, Cell Signaling, 1:50), goat anti-BCAM (AF8299, R&D Systems, 1:50), chicken anti-GFP (ab13970, Abcam, 1:500), rabbit anti-GFP conjugated to AF488 (A21311, Invitrogen, 1:250), goat anti-Integrin beta 1 (AF2405, R&D Systems, 1:50), rabbit anti-laminin α4 (serum 377, 1:500), rat anti-laminin α5 (clone 4G6, 1:10), rabbit anti-fibronectin (F3648, Sigma, 1:100), rabbit anti-collagen Type1 (AB765P, Millipore, 1:100), goat anti-osteopontin (AF808, R&D Systems, 1:100), α-SMA-Cy3 (C6198, Sigma, 1:50), mouse antihypoxyprobe conjugated to fluorescein isothiocyanate (FITC) (no. FITC-Mab, Hydroxyprobe, 1:50), rabbit anti-phospho-ERK1/2 (D13.14.4E, Cell Signaling, 1:50), rabbit anti-osteocalcin (LS-C17044, LifeSpan BioSciences, 1:300), rabbit anti-NG2 (AB5320, Millipore, 1:100), rat anti-Runx2 (MAB2006, R&D Systems, 1:50), rabbit anti-calcitonin receptor (ab11042, Abcam , 1:50), rabbit anti-TRAP (sc-28204, Santa Cruz, 1:50).
The following secondary antibodies were used: donkey anti-rat coupled to Cy3 (712-165-150, Jackson ImmunoResearch, 1:250), donkey anti-rat coupled to AF594 (A21209, Invitrogen, 1:250), chicken anti-rat coupled to AF647 (A21472, Invitrogen, 1:350), donkey anti-goat coupled to AF647 (A21447, Invitrogen, 1:350), donkey anti-goat coupled to AF488 (A11055, Invitrogen, 1:350), donkey antirabbit coupled to AF647 (A31573, Invitrogen, 1:350), donkey anti-rabbit coupled to AF488 (A21206, Invitrogen, 1:350), donkey anti-rabbit coupled to AF546 (A10040, Invitrogen, 1:350), donkey anti-chicken coupled to AF488 (703-545-155, Jackson ImmunoResearch, 1:350). Nuclei were counterstained with Hoechst 33342 (H3570, Invitrogen, 1:1000).
EdU labelling was performed according to the manufacturer's instructions (Invitrogen).
Dissection, processing, sectioning, staining, imaging and analysis for phenotypes of mutant mice and controls were always performed together under identical conditions. Image acquisition and quantitative analysis. Stained bone sections were analysed at high resolution with a Leica TCS SP5 confocal microscope. Z-stacks of images were processed and three-dimensionally reconstructed with Imaris software (version 7.00, Bitplane). Photoshop CS5 and Illustrator CS5 (Adobe) were used for image processing. Quantitations were performed with Volocity (Version 6.0.1, Perkin Elmer) on high-resolution images.
For Fig. 1e , the left graph shows the sum of the osterix immunosignal within the primary ossification centre, as measured with Volocity software. The graph on the right shows the sum of the osterix immunosignal normalized to the area of the primary ossification centre.
All images shown are representative for the respective staining in several experiments. Within one experiment laser excitation and confocal scanner detection were the same.
Flow cytometry. Tibiae and femurs were dissected from mice of interest and pooled. All adjacent tissue was removed thoroughly. After removal of the epiphysis, bones were crushed in ice-cold PBS using a mortar and pestle. To obtain a singlecell suspension, samples were digested with collagenase for 20 min at 37 • C and filtered. Subsequently, samples were treated with blocking solution (1% FCS) for 30 min, washed with PBS and immunostained with rat anti-endomucin antibody (sc-65495, Santa Cruz, 1:50) for 45 min on ice. After washing, cells were stained with goat anti-CD31 coupled to AF488 or allophycocyanin (APC) antibody (FAB3628G or FAB3628A, R&D Systems, 1:10) and donkey anti-rat antibody coupled to phycoerythrin (PE) (712-116-153, Jackson Immunoresearch, 1:100) or donkey antirat antibody coupled to DyLight405 (712-475-150, Jackson Immunoresearch, 1:200) for 45 min on ice. After thorough washing, cells were treated with DAPI to exclude dead cells. Finally, cells were acquired on a BD FACSVerse flow cytometer and analysed using BD FACSuite Software (Version 1.0.5.3841, BD Bioscience). Cell sorting was performed with a FACS Aria II.
Labelling of proliferating cells with EdU (Invitrogen) was done according to the manufacturer's instructions.
RNA sequencing and data analysis. Femurs and tibiae of 20 wild-type P6 mice were pooled and sorted by flow cytometry for type H, type E and type L ECs. RNA from 120,000 cells from each group was isolated using the RNeasy Plus Micro Kit (QIAGEN) according to the manufacturer's instructions. RNA quality was checked using a 2100 BioAnalyzer (Agilent). One hundred nanograms of RNA was used for preparation of sequencing libraries with the TruSeq Stranded Total RNA Library Prep Kit (Illumina) according to the manufacturer's instructions. Libraries were validated using a BioAnalyzer and quantified by qPCR. Libraries were diluted to a final concentration of 15 pM for sequencing. The MiSeq Reagent Kit v3 (Illumina) was used for sequencing with a MiSeq (Illumina). The experiment was performed in triplicates.
Quality assessment. The quality assessment of raw sequence data of endothelial cell subtypes H, E and L was performed using FastQC (Version: FastQC 0.11.3, http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). No samples were discarded from the analysis.
Alignment to reference sequence. Paired-end sequence reads were mapped to the mm10 mouse genome assembly (GRCm38) using TopHat-2 with the following settings (Version: tophat-2.0.13; [tophat2 -g 2]) 63 . The mouse genome was downloaded from the iGenome portal (https://support.illumina.com/sequencing/ sequencing_software/igenome.html). HTSeq was used to count the aligned reads on a per gene basis using the following settings (Version: HTSeq-0.6.1; [htseq-count -mode=intersection-nonempty-stranded=reverse]) 64 . RNA-sequencing data were uploaded to ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) with the accession number E-MTAB-4066.
Differential gene expression analysis. The count data were normalized using the Variance Stabilizing Transformation (VST) function from the DESeq2 package (ref. 11). Principal component analysis was performed on transformed read counts using the top 500 most variable genes to assess the overall similarity between the samples 65, 66 . Differential gene expression analysis between the H versus L, E versus L and E versus H groups was performed using DESeq2. Differentially expressed genes were selected using an FDR-adjusted P value cutoff <0.01 and an absolute log 2 fold change >1. Gene symbols were annotated using biomaRt (BioConductor version 3.1). Lists of differentially regulated genes for the different contrasts are provided in Supplementary Tables 3-5 .
Functional analysis. Gene-set enrichment analysis was performed using Generally Applicable Gene-set Enrichment (GAGE; BioConductor version 3.1) 37 . For functional annotation, we used gene sets from org.Mm.eg.db, a genome-wide annotation package for mouse (Bioconductor, version 3.1). The analysis was performed on the basis of one-on-one comparisons between H versus L and E versus L subtypes where L was always used as a control data set. For this analysis, read counts were normalized as described in the GAGE vignette (Bioconductor, version 3.1). Significant GO terms were selected using an FDR-adjusted P value <0.0001. Lists of enriched GO terms in upregulated gene sets are provided in Supplementary  Tables 1 and 2. Quantitative RT-PCR. RNA was isolated from flow cytometrically sorted bone marrow endothelial cells using the RNeasy Plus Micro Kit (QIAGEN) according to the manufacturer's instructions. The iScript cDNA Synthesis Kit (BIO-RAD) was used to transcribe 100 ng RNA per reaction into cDNA. The quantitative PCR (qPCR) was performed on an ABI PRISM 7900HT Fast Real Time PCR System (Applied Biosystems). The following FAM-conjugated TaqMan gene expression probes were used in combination with TaqMan Gene Expression Master Mix (Life Technologies):
VIC-conjugated ActB(4352341E) TaqMan probe was used to normalize gene expression. Per group at least six mice from three independent litters were analysed to obtain the relative expression differences.
ELISAs. Serum levels of parathyroid hormone and calcitonin were measured by quantitative enzyme-linked immunosorbent assay (ELISA) kits (CEA866Mu and CEA472Mu, Cloud-Clone Corp.) in blood samples from mutant and control mice.
Second-harmonic generation (SHG) imaging using multi-photon microscopy.
A TriM Scope II multi-photon system from LaVision BioTec was used for SHG imaging to visualize anisotropic structures, such as collagen fibres. The microscope set-up is a single-beam instrument with an upright Olympus BX51 WI microscope stand equipped with high-sensitivity non-descanned detectors close to the objective lens.
The TriM Scope II is fitted with a Coherent Scientific Chameleon Ultra II Ti:Sapphire laser (tuning range 680-1,080 nm) and a Coherent Chameleon Compact OPO (automated wavelength extension from 1,000 nm to 1,600 nm). A 20× IR objective lens (Olympus XLUMPlanFl 20×/1.0 W) with a working distance of 2.0 mm was used. SHG signals were detected using TiSa light at 850 nm, a 420/40 band-pass filter and a blue-sensitive photomultiplier (Hamamatsu H67080-01). Three-dimensional images were acquired and processed with LaVision BioTec ImSpector Software under Microsoft Windows. Overview images were reconstructed from a sequence of tiled three-dimensional images with Image J.
Micro-computed tomography. Dissected tibiae were cleaned from adjacent tissue, fixed overnight in 4% PFA at 4 • C and analysed using µCT. Measurements were carried out by Scanco Medical AG, Switzerland. The chosen voxel size was 6 µm in all three spatial dimensions. For each sample, 248 slices were evaluated, covering a total of 1.488 mm, X-ray voltage was 70 kVp, intensity 114 µA, integration time 300 ms, frame averaging 4.
Cell culture experiments. Mouse C3H10T1/2 cells (no. CCL-226, ATCC) were cultured in Dulbecco's modified Eagle's medium (Sigma), supplemented with 10% FBS (PAA Laboratories), 2 mM L-glutamine, 100 U ml −1 penicillin, and 100 mg ml −1 streptomycin (Invitrogen). Cultured cells were maintained at 37 • C in a humidified 5% CO 2 atmosphere.
For co-culture spheroids, freshly sorted EC subpopulations were combined with C3H10T1/2 cells by the hanging-drop method. In brief, equal numbers of suspended C3H10T1/2 cells and sorted ECs or an equal number of only C3H10T1/2 cells (5,000 cells per spheroid) were suspended in spheroid-formation media consisting of DMEM containing 1% FBS, 0.05% (w/v) polyvinyl alcohol (PVA; Sigma-Aldrich), N2 supplement and 0.25% (w/v) methylcellulose (Sigma-Aldrich; M-0512, 4000 c.p.). Drops of 17 µl cell suspension were placed onto each position of a 96-well plate lid. The lids were flipped on and placed on non-adherent round-bottom 96-well plates, which were kept at 37 • C in a humidified 5% CO 2 incubator overnight to generate spheroids. Forming spheroids were seeded into each well with a plate spin, and then cultured for 7 days with spheroid culture media of DMEM containing 1 % FBS, 0.05 % (w/v) polyvinyl alcohol (PVA; Sigma-Aldrich), N2 supplement.
For immunostaining, spheroids were embedded into 2% low melting agarose gel. For easy detection of ECs in spheroids, each endothelial population was labelled with the lipophilic fluorescent dye CM-DiI (1 µM; Invitrogen) for 10 min at 37 • C, and then for an additional 20 min at 4 • C. Cells were then washed with complete culture medium twice. DiI-labelled ECs were combined with C3H10T1/2 cells as described above.
ALP staining was performed after 7 days of culture in spheroid culture media. ALP activity was detected with Leukocyte Alkaline Phosphatase Kit (Sigma 86R) following the manufacturer's instructions.
Cell lines used in this study were tested for mycoplasma contamination, were not authenticated and are not listed in the database of commonly misidentified cell lines that is maintained by ICLAC and NCBI Biosample.
Statistics and reproducibility. Statistical analysis was performed using Graphpad
Prism software or the R statistical environment (http://r-project.org). All data are presented as mean ± s.e.m. unless indicated otherwise. Unpaired two-tailed Student t-tests were used to determine statistical significance. P < 0.05 was considered significant unless stated otherwise. All experiments were performed independently at least three times (unless noted otherwise in the respective figure legend) and respective data were used for statistical analyses. Sample sizes for each experiment are described in the respective figure legends, and source data from independent replicates are provided in Supplementary Supplementary Figure 7 Apln-CreER-controlled Itgb1 mutants. a, Scheme showing the time points of tamoxifen administration and analysis for Apln-CreER R26-mT/mG and Itgb1 iΔApln mice. b, Overview of P10 femur of Apln-CreER R26-mT/mG mice without tamoxifen-induced recombination. Note absence of GFP+ cells (green). Nuclei, Hoechst (blue). c, d, Overview and high magnification confocal images of GFP signal (green) and Emcn staining (red) in femur, metaphysis and endosteum of Apln-CreER R26-mT/mG mice P13 (c) and P21 (d). Nuclei, Hoechst (blue). e, Body weight of Itgb1 iΔApln mutants relative to Cre-littermate controls. Data represents mean± s.e.m. (n=9) (p<0.001, unpaired twotailed t-test). f, Quantitation of Itgb1 iΔApln and Cre-littermate control femoral length. Data represents mean± s.e.m. (n=9) (p<0.001, unpaired two-tailed t-test). g, Representative 3D reconstruction from µCT measurements of 3 week-old Itgb1 iΔApln and littermate control tibial metaphysis. h, Diagrams represent bone parameters measured in µCT analyses: bone volume/total volume (BV/TV) in percentage, trabeculae number in 1 per millimeter, trabecular thickness in millimeters, and trabecular separation in millimeters. Data represent mean± s.e.m. (n=6 controls and 4 mutants), (p-values determined by two-tailed unpaired t-test). Statistics source data are shown in Supplementary Table 6 . i, Confocal images of TRAP immunosignal (green) in 3 week-old control or Itgb1 iΔApln femur. Nuclei, Hoechst (blue). 
